Home Health Care Quality, Its Costs and Implications for Home Health Value-Based Purchasing.

ABSTRACT: The Home Health Value-based Purchasing (HHVBP) demonstration, incorporating a payment formula designed to incentivize both high-quality care and quality improvement, is expected to become a national program after 2022, when the demonstration ends. This study investigated the relationship between costs and several quality dimensions, to inform HHVBP policy. Using Medicare cost reports, OASIS and Home Health Compare data for 7,673 home health agencies nationally, we estimated cost functions with instrumental variables for quality. The estimated net marginal costs varied by composite quality measure, baseline quality, and agency size. For four of the five composite quality measures, the net marginal cost was negative for low-quality agencies, suggesting that quality improvement was cost savin

SUBMITTER: Mukamel DB 

PROVIDER: S-EPMC8323610 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature